Form 4 for NEO NEOGENOMICS INC
Accepted 2026-08-25 16:33:08 ET · period of report 2026-08-21 · accession 0001628280-26-058913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-25 16:33 | 2026-08-21 | NEO | Stone Warren | Pres, COO | M - OptEx | $0.00 | +28.1K | 192.1K | +17% | $0 |
| D | 2026-08-25 16:33 | 2026-08-21 | NEO | Stone Warren | Pres, COO | F - Tax | $0.00 | -11.1K | 181.1K | -6% | $0 |
| D | 2026-08-25 16:33 | 2026-08-21 | NEO | Stone Warren | Pres, COO | M - OptEx | $0.00 | -28.1K | 28.1K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-21 | M | A | 28,106 | $0.00 | 192,138 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-21 | F | D | 11,060 | $0.00 | 181,078 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-08-21 | M | D | 28,106 | $0.00 | 28,106 | D | $0.00 · — to — | 28,106 Common Stock | (F1) On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date. (F2) Once vested, the shares of common stock are not subject to expiration. |